Company Name: |
Alinda Chemical Ltd.
|
Tel: |
+7 (495) 672-17-08 |
Email: |
sale@alinda.ru |
Products Intro: |
CAS:345989-24-4 Package:1mg Remarks:C20H15N5O3S
|
Company Name: |
Energy Chemical
|
Tel: |
021-58432009 400-005-6266 |
Email: |
marketing@energy-chemical.com |
Products Intro: |
Product Name:MIND4-17 >=98% (HPLC) CAS:345989-24-4 Purity:NULL Package:1ea;25mg;5mg Remarks:NULL
|
Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
15002134094 |
Email: |
marketing@targetmol.cn |
Products Intro: |
Product Name:MIND4-17 CAS:345989-24-4 Package:25mg/RMB 10600;50mg/RMB 13800;100mg/RMB 17500
|
5-nitro-2-[[5-(phenoxymethyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]pyridine manufacturers
- MIND4-17
-
- $1520.00 / 25mg
-
2024-10-28
- CAS:345989-24-4
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| 5-nitro-2-[[5-(phenoxymethyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]pyridine Basic information |
| 5-nitro-2-[[5-(phenoxymethyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]pyridine Chemical Properties |
Boiling point | 667.5±65.0 °C(Predicted) | density | 1.39±0.1 g/cm3(Predicted) | storage temp. | 2-8°C | solubility | DMSO: 2mg/mL, clear (warmed) | form | Solid | pka | -0.38±0.10(Predicted) | color | Off-white to light yellow |
| 5-nitro-2-[[5-(phenoxymethyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]pyridine Usage And Synthesis |
Biological Activity | MIND4-17 is a potent NRF2 (nuclear factor erythroid 2-related factor 2) activator th at covalently modifies a critical stress-sensor cysteine (C151) in the BTB domain of the E3 ligase substrate adaptor protein Kelch-like ECH-associated protein 1 (KEAP1), the primary negative regulator of NRF2. MIND4-17 induces NRF2 activation responses in neuronal and non-neuronal cultures (effective conc. 0.1-10 μM) of human, mouse, and r at origins. In addition, MIND4-17 effectively reduces endotoxin-induced IL-6 release from WT as well as YAC128 HD mutant mice-derived primary microglia and astrocytes, however, NRF2 induction by MIND4-17 is shown to be compromised in human Huntingtonμs diseased (HD) relative to non-disesed neural stem cells due to suppressive influence of the expanded CAG repe at mutation on pathway activation. |
| 5-nitro-2-[[5-(phenoxymethyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]pyridine Preparation Products And Raw materials |
|